MeMed https://validator.w3.org/feed/docs/rss2.html BBC Radio Highlights MeMed BV’s Role in the NHS-Funded Trial Aimed at Improving Diagnosis in Children with Suspected Infections. {from minute 19:28} Home MeMed Expands Global Footprint as Health Canada Approves MeMed BV on MeMed Key FDA Grants Breakthrough Device Designation to MeMed BV Flex™ Capillary Blood 2021 Dun & Bradstreet’s Best Companies to Work For After a decade and 130 million dollars, the MeMed test receives FDA clearance Maimonides Medical Center adopts revolutionary technology that quickly.. MeMed raises $93M to accelerate commercialization of its host immune-response… DiaSorin receives FDA 510(K) clearance for Its LIAISON MeMed BV test FDA Grants Breakthrough Device Designation to MeMed’s Capillary Blood Infection Test MeMed Receives FDA Breakthrough Device Designation for Capillary Blood Version of BV Test Maccabi Healthcare Services Announces it is the First HMO in the World to Include… Know Thy Enemy: MeMed’s Diagnostic Reduces Antibiotic Overuse in U.S. Trial Determining If the Patient’s Infection is Bacterial or Viral Trial shows MeMed BV reduces use of unnecessary antibiotics Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief MeMed BV Test Demonstrates Antibiotic Overuse Reduction in First US Interventional Trial FDA Grants Breakthrough Designation Status for Test for Patients with Suspected Sepsis MeMed: Beat Müller, Dave Hickey, David Shulkin Smiles or Standards? How Satisfaction Surveys Influence ED Decisions More than 100,000 patients tested with MeMed BV New Sepsis Testing Tools Emerging While Adoption Drags Amid Clinical Utility Concerns Data on the utility of MeMed BV to be presented at ACEP25 NHS Trialling Rapid Blood Test to Help Diagnose Sepsis and Meningitis in Children MeMed Bacterial-Viral Blood Test Trialed in UK Case Examples Landing Page: MeMed at AACC 2023 Form Landing Page: MeMed at AACC 2023 Landing Page: How Does it Work Video Events Tiny Patients, Big Decisions: The Delicate Balance of Antibiotics in Pediatric Care Glyphosate and Human Health: Navigating the Maze of Uncertainty UTILIZATION for Patients UTILIZATION for Healthcare Providers Google Ads: UTILIZATION Pop Up Google Ads: AWARENESS Pop Up FAQ Contact Careers Beyond the Score Bacterial vs Viral Awareness for Patients MeMed BV Flex Receives FDA Breakthrough Device Designation Awareness for Healthcare Providers Auto Draft Antimicrobial Resistance Page MeMed BV Flex Gets Breakthrough Device Designation Our Team Publication: Diagnostic accuracy of MMBV in predicting bacterial infection in febrile children: a systematic review and meta-analysis MeMed Awarded $2 Million Grant to Establish a First-of-Its-Kind Acute Care Digital and Physical Biobank